Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Oral estrogen therapy increases the risk of venous thromboembolism (VTE) in postmenopausal
women. Transdermal estrogen may be safer. However, currently available data have limited
the ability to investigate the wide variety of types of progestogen.